Učitavanje...

Initiation of Adjuvant Hormone Therapy by Medicaid Insured Women With Nonmetastatic Breast Cancer

Hormone therapy is the mainstay of adjuvant treatment for hormone receptor positive (HR-positive) nonmetastatic breast cancer. We evaluated adjuvant hormone therapy (AHT) initiation among Medicaid-insured women aged 21–64 years with stage I–III HR-positive breast cancer. We used multivariable logist...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yung, Rachel L., Hassett, Michael J., Chen, Kun, Gesten, Foster C., Roohan, Patrick J., Boscoe, Francis P., Sinclair, Amber H., Schymura, Maria J., Schrag, Deborah
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2012
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3731435/
https://ncbi.nlm.nih.gov/pubmed/22773822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djs273
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!